Skip to main content
. 2020 Sep 30;12(10):2816. doi: 10.3390/cancers12102816

Table 2.

Genetic variants found in TP53, PIK3CA, homologous recombination (HR), and mismatch repair (MMR) genes detected in 21 inflammatory breast carcinomas assessed by tNGS *.

Cases TP53 PIK3CA HR gGenes MMR Genes
IBC1 c.3140A>G;p.His1047Arg
IBC2 c.1633G>A; p.Glu545Lys
IBC4 ATM (c.3887C > G; p.Pro1296Arg)
PG, Loss
IBC5 BRCA2 (c.4963_4964insA; p.Tyr1655Ter)
Loss
IBC6
IBC7 BRCA2 (C.2806_2809delAAAC; p.Ala938Profs)
cnLOH
MLH1 (c.2146G > A; p.Val716Met)
PG, Loss
IBC8 c.512A > G; p.Glu171Gly
PG, Loss
IBC9 BRCA2 (c.5682C > G; p.Tyr1894Ter)
Loss
RAD51B (c.728A > G; p.Lys243Arg)
cnLOH
POLD1 (c.1055G > A; p.Arg352His)
Gain
IBC10 BRCA2 (c.2T > G; p.Met1?)
IBC11 c.309C > A; p.Tyr103Ter
Gain and cnLOH
BRCA2 (c.316+1G >T)
Gain and cnLOH
RAD51B (c.315+8A > G)
PG, Gain and cnLOH
MSH6 (c.3961A > G; p.Arg1321Gly)
PG
IBC12 c.659A > G; p.Tyr220Cys
PG, cnLOH
RAD51D (c.899G > A; p.Arg300Gln)
PG, Loss
PMS2 (c.2186_2187delTC; p.Leu729Glnfs)
PG, Gain
IBC13 c.712T > G; p.Cys238Gly
PG
BRCA2 (c.6988A > G; p.Ile2330Val)
PG
IBC14 c.586C > T; p.Arg196Ter
PG, Loss
BRCA2 (c.8869C > T; p.Gln2957Ter)
Loss
IBC15 PALB2 (c.43G > T; p.Glu15Ter)
cnLOH
MSH3 (c.1567G > A; p.Glu523Lys)
PG
MSH3 (c.1571A > C; p.Asn524Thr)
PG
IBC16 c.856G > A; p.Glu286Lys
Loss and cnLOH
MSH3 (c.2436-5C > G
Gain
IBC18 c.626_627delGA; p.Arg209Lysfs
PG, Loss
c.3140A > T; p.His1047Leu BRCA2 (c.9227G > T; p.Gly3076Val)
Loss
IBC20 c.578A > T; p.His193Leu
PG
c.560-2A > C
PG, Loss
c.1035T > A; p.Asn345Lys BRCA1 (c.3858delT; p.Ser1286Argfs)
PG, Loss
MLH3 (c.2638C > G; p.Leu880Val)
PG
IBC22 c.731G > A; p.Gly244Asp
Loss and cnLOH
c.3140A > G; p.His1047Arg MUS81 (c.416G > A; p.Arg139Gln)
PG
PMS2 (c.2383G > A; p.Asp795Asn)
PG
IBC24 c.844C > T; p.Arg282Trp
PG, Loss
MSH6 (c.1406A > G; p.Tyr469Cys)
PG
IBC25
IBC26 c.542G > A; p.Arg181His
PG, Loss:

* Copy number alterations and Variant Allele Frequency (VAF) of TP53, HR and MMR genes presenting genetic variants are shown. (c.) and (p.) indicate the coding sequence and the amino acid position according to HGVS (Human Genome Variation Society), respectively. cnLOH, copy number loss of heterozygosity; PG, potentially germline variant (VAF, <0.5). Copy number loss < 2.0; Copy number gain > 2.0.